News - NLSDays - NLSDays

Latest news in cooperation with Nordic Life Science

AGC Biologics completes Copenhagen campus expansion

24 July 2024 | 5:48 am

The company estimates this will create several hundred more jobs, which they will begin filling this year. The grand opening of the new facility, held on June 18th, hosted elected officials and leaders from the Danish political and life science community, including the Ministry of Taxation, the Japanese Ministry in Denmark, and the Mayor of […]

A treatment shift? – Nordic progress beyond GLP-1

22 July 2024 | 7:00 am

In the wake of the groundbreaking GLP-1 receptor agonists, a number of new obesity treatments and weight management approaches are emerging – and a few of them come from the Nordic region. Behavior Lifestyle changes are critical for weight loss, even for patients taking the GLP-1 anti-obesity drugs, and we all know that implementing and […]

Qlife ApS terminates corporate restructuring and files for bankruptcy

22 July 2024 | 5:14 am

Qlife Holding has received information that Qlife ApS’s reconstructor will terminate the corporate restructuring. The board of directors has consequently decided to file for bankruptcy for the subsidiary, Qlife ApS. On 4 April 2024, the company announced that Qlife ApS was undergoing reconstruction to address creditor issues and to manage short-term liquidity. Since then, the […]

Highlighting Norwegian start-ups

17 July 2024 | 5:23 am

AdjuTec Pharm is first out in the new series “the Start-up Spotlight”, which features the most promising start-ups from the Norwegian health clusters. The series The Start-up Spotlight and The Scale-up Spotlight are produced in collaboration between the Norwegian health clusters: Norway Health Tech, Oslo Cancer Cluster, The Norwegian Smart Care Cluster, The Life Science […]

“I am glad to have contributed direct answers to human biology”

16 July 2024 | 5:23 am

SmartCella raises EUR 50 million and enters license agreement

15 July 2024 | 5:11 am

SmartCella has announced a new share issue to accelerate growth and support commercialization of the Extroducer and the company’s cell and mRNA operations. The share issue was supported by existing large institutional investors such as Fjärde AP-fonden, AMF Pension and SEB-Stiftelsen, as well as a new long-term strategic investor, AstraZeneca (committing to approximately half of […]

Orion and MSD announce mutual exercise of option

11 July 2024 | 5:16 am

Orion Corporation and MSD have announced that notice has been provided of the mutual exercise of an option to convert the companies’ ongoing co-development and co-commercialization agreement for opevesostat, an investigational CYP11A1 inhibitor, and other candidates targeting CYP11A1 into an exclusive global license for MSD. “The conversion of this collaboration into a license agreement allows […]

The winners of the Wolf Prize 2024 in the field of medicine

10 July 2024 | 5:41 am

Botond Roska and José-Alain Sahel have been awarded the Wolf Prize in Medicine for their pioneering work on restoring vision to blind patients using optogenetic therapy. The Wolf Prize recognizes outstanding achievements in various fields including medicine. Botond Roska and José-Alain Sahel Roska, Director at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and […]

Multi-faceted action and a comprehensive nationwide strategy

10 July 2024 | 4:00 am

Obesity is a chronic disease that requires continuous interdisciplinary research to find and develop effective new tools for prevention and treatment. NLS asked the Finnish Association for the Study of Obesity (FASO) about the Nordic region’s challenges and efforts within obesity. How would you describe the impact that drugs like semaglutide have had on obesity […]

Hadean Ventures co-leads investment into SciRhom

9 July 2024 | 7:30 am

Hadean Ventures co-led the EUR 63 million Series A financing round, together with a consortium of international investors. In conjunction with this investment, Georgina Askeland, Senior Associate at Hadean Ventures, will join SciRhom’s board of directors. “SciRhom has a unique approach that ticks all the boxes in I&I. In one stroke, their highly selective iRhom2 […]

Latest news in cooperation with Nordic Life Science

AGC Biologics completes Copenhagen campus expansion

A treatment shift? – Nordic progress beyond GLP-1

Qlife ApS terminates corporate restructuring and files for bankruptcy

Highlighting Norwegian start-ups

“I am glad to have contributed direct answers to human biology”

SmartCella raises EUR 50 million and enters license agreement

Orion and MSD announce mutual exercise of option

The winners of the Wolf Prize 2024 in the field of medicine

Multi-faceted action and a comprehensive nationwide strategy

Hadean Ventures co-leads investment into SciRhom

Join the conference!

Join the conference!

© 2024 SwedenBIO. All Rights Reserved
Legal Notices

Latest news in cooperation with Nordic Life Science

Join the conference!

© 2024 SwedenBIO. All Rights ReservedLegal Notices

© 2024 SwedenBIO. All Rights Reserved
Legal Notices